-
The working principle of nucleic acid detection reagent filling machine
Time of Update: 2022-04-25
When the main machine is working, the liquid in the storage tank is pumped into the piston cylinder, and then filled into the bottle through the nozzle .
-
In 2021, the performance of domestic CRO/CDMO manufacturers is sorted out, and the industry development trend
Time of Update: 2022-04-25
Heyuan Bio, Wea Bio, Medici Bio, Pioneer Bio and Boji Bio, GenScript Bio In general, the CRO and CDMO businesses of leading companies have grown rapidly, and the popularity and valuation of this vertical capital are very high .
-
Features of vacuum feeder
Time of Update: 2022-04-25
The material is collected in the silo, our cyclone prevents the fine powder from entering the filter to improve the efficiency of the filter, when the silo is full of material, the vacuum pump is automatically turned off, the pressure in the conveying equipment is balanced, and the discharge valve is opened , the material flows out through the discharge port and falls directly into the storage container.
-
What are the characteristics of automatic powder filling and sealing machine
Time of Update: 2022-04-25
4. The powder filling machine has high positioning accuracy, large torque, long life and adjustable speed .
7. The powder filling machine is fully sealed with air damping glass and stainless steel composite material box.
-
The seventh batch of national mining, the latest news
Time of Update: 2022-04-25
Compared with the previous arrangement, the progress has been delayed by about two months The above-mentioned person further pointed out that if the centralized procurement documents are successfully released before March, according to the original arrangement, the seventh batch of national procurement will be able to enter the results release stage from April to May .
-
The four departments to support the overseas listing of enterprises jointly revise the rules for overseas issuance, listing and verification of enterprises
Time of Update: 2022-04-25
On April 2, the China Securities Regulatory Commission, together with the Ministry of Finance, the State Secrecy Administration and the State Archives Administration, publicly solicited opinions on t
-
The number of infected people in Shanghai is increasing by nearly 20,000. When will the turning point come?
Time of Update: 2022-04-16
Four days after the "big battle" of the epidemic in Shanghai, the city with a population of 25 million has not yet lifted the blockade, and a new round of nucleic acid testing is underway .
-
Nature: Evolution of China's innovative drug R&D
Time of Update: 2022-04-16
Next-gen drugs are further classified into cell therapy, bispecific/multispecific antibodies, antibody-drug conjugates, gene therapy, oncolytic viruses, nucleic acids, proteolytic targeting chimeras, nucleic acid vaccines and others Next-generation drugs (not belonging to any next-generation group); FIC, first-in-class; FF, fast-follower; M2, me-too; n/a, products that cannot be classified due to insufficient information .
-
2021 Top 8 pharmaceutical companies with the highest net income in the world: Novartis' first Moderna enters the list with the new crown vaccine
Time of Update: 2022-04-16
108 billion Headquartered in Switzerland, Novartis has a pipeline of best-selling drugs in the fields of ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory and cardiovascular .
2 billion Moderna mainly develops mRNA therapeutics, and its only current product is a COVID-19 vaccine .
-
Coordinate Shanghai!
Time of Update: 2022-04-15
5) issued by the General Office of the Shanghai Municipal People's Government, and to accelerate the construction of an innovative highland for the biomedical industry with international influence, Promote the high-quality development of the biopharmaceutical industry, reduce the innovation risks of relevant enterprises, hospitals and other units, and plan to establish a liability insurance compensation mechanism for biomedical human clinical trials in this city, and implement premium subsidies for qualified clinical trials of drugs, medical devices and medical technologies.
-
Works on Omicron!
Time of Update: 2022-03-07
S. Food and Drug Administration (FDA) announced the approval of an Emergency Use Authorization (EUA) for Eli Lilly’s new crown neutralizing antibody, Bebtelovimab, for the treatment of mild to moderate COVID-19 in adults and pediatric patients (at least 40 kg) aged 12 years and older.
-
Targeting STING and the inflammasome with $140 million to drive innovative therapies into the clinic
Time of Update: 2022-03-07
Its lead drug program targets key regulators in the innate immune system, including NLRP3 and cGAS, which are involved in the development of a variety of diseases .
Ventus' third project targets cyclic GMP-AMP synthase (cGAS), a key regulator of the stimulator of interferon genes (STING) pathway .
-
What's behind the NMPA's emergency approval of Pfizer's new coronavirus drug import?
Time of Update: 2022-03-07
On February 12, 2022, the State Food and Drug Administration announced that Pfizer's new coronavirus treatment drug nematevir tablet/ritonavir tablet combination package import registration has been approved with emergency conditions .
-
CSPC took the lead in buying the bottom, and the domestic Biotech selling tide is about to start
Time of Update: 2022-03-07
The inevitable result of the trend of the times Some people say that Mingkang Bio's "selling body" opened the prelude to the big pharmaceutical company's bottom-hunting Biotech, which is true .
-
Research tools for anticancer drug targets
Time of Update: 2022-03-07
Table 1: FDA-approved treatments for PD-1 and PD-L1 In addition to this, researchers are currently actively investigating new targets, including T-cell immune receptors (TIGITs) with Ig and EM domains .
-
2022 China's new drug FDA chapter
Time of Update: 2022-03-07
However, by 2022, most people in the Chinese pharmaceutical industry are already ignorant of what is a real new drug, although they are reluctant to admit that basically no one does not understand that China's new ME COPY drug is really not a new drug .
-
2021 MNC TOP20 drugs: K drugs will break the $20 billion mark, O drugs will increase by 8%
Time of Update: 2022-03-07
In addition to Pfizer's new crown vaccine, the old drug king Humira, still has sales exceeding 20 billion in 2021.
In addition to the new crown vaccine products, K medicine is regarded as the next super blockbuster drug that is most expected to exceed 20 billion US dollars .
-
The Food and Drug Administration approved the import registration of Pfizer's new crown treatment drug Paxlovid, which will become the second new crown specific drug in my country
Time of Update: 2022-03-07
The performance of Paxlovid is comparable to the therapeutic effect of the new crown neutralizing antibody, and it is also significantly better than the broad-spectrum antiviral drug Monlnupiravir developed by Merck & Co. On November 5, 2021, Pfizer announced the results of a Phase III clinical study of Paxlovid, which showed that patients with mild to moderate new crowns who took the drug within 3 days of diagnosis could reduce the risk of hospitalization and death by about 89% .
-
It's about to usher in the launch period!
Time of Update: 2022-03-06
In response to the mismatch between light and heavy chains, bispecific antibody research and development companies have launched technical platforms for IgG and non-IgG double antibodies .
-
WuXi is listed on the "sanctions" list, how to play the card of domestic CRO going overseas?
Time of Update: 2022-03-06
In 1999, Li Ge, who is well-known in the field of global pharmaceutical and medicinal chemistry, returned to China to investigate and found that although domestic pharmaceutical research institutions already have certain R&D capabilities in the field of original research drugs, advanced production technology is still in the hands of foreign pharmaceutical companies.
